Results

Total Results: 1,744 records

Showing results for "drugs".

61. Section 1, Tables 1 and 2 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-tables-1-2.pdf
    June 02, 2025 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β-blocker drugs

62. Section 1, Tables 1 and 2 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-1-tables-1-2.pdf
    June 02, 2025 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β- blocker drugs

63. Section 1, Tables 1 and 2 (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-1-tables-1-2.pdf
    June 02, 2025 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β- blocker drugs

64. Final Progress Report: Risk Models To Improve Long-Term Care Medication Safety (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/higginson-report.pdf
    January 01, 2024 - LTC nurses, aides, and caregivers often administer the same drugs to the same patients for years. … Q:0.01 G t 417 Drugs pulled ... Q:3e-006 E t714 Percentage ... … By exposure alone, blister pack drugs dominated the risk model. … Drugs Aging. 1995:7(3):203-11. 8 Bates DW, Boyle DL, Vander Vliet, et al. … Most common drug classes involved in errors were antimicrobials and cardiovascular drugs.

65. Anemia Increasing in Hemodialysis Patients, Especially for Blacks (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/dataspotlight-anemia-dialysis.pdf
    December 02, 2019 - Safe Use of Erythropoiesis-Stimulating Agents (ESAs) in Chronic Kidney Disease. https://www.fda.gov/drugs … kidney_factsheet.pdf https://www.cdc.gov/kidneydisease/pdf/kidney_factsheet.pdf https://www.fda.gov/drugs … fda-drug-safety-communication-modified-dosing-recommendations-improve-safe-use-erythropoiesis https://www.fda.gov/drugs

66. Data Resources | Agency for Healthcare Research and Quality
    www.ahrq.gov/data/resources/index.html?page=3
    Prescription Drug Use MEPS- Household Component survey participants are asked about their prescription drugs … No information is collected for prescription drugs obtained during hospital visits.

67. National Collaborative for Innovation in Quality Measurement (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-section-2-technical-specs.pdf
    May 23, 2014 - Numerator Received two or more prescriptions for an antipsychotic medication (for the same or different drugs … who received two or more prescriptions for an antipsychotic medication (for the same or different drugs … Note: For medications in Table XXX-A, identify different drugs using the Drug ID field located in the

68. Final Progress Report: Clinical Decision Support Simulations for Medication Administration Safety (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/moss-berner-report.pdf
    January 01, 2024 - become available, some drugs are infrequently given, and interruptions, fatigue, and overwork are … Other areas of immediate concern when administering drugs were also related to administration, such … to actual patient intravenous access available to provide a mapping of how multiple drugs could be … The number of ports, the drugs…and link that. … “What surprised me I guess …the most was trying to learn this system and doing different drugs and

69. Improving Antipsychotic Appropriateness in Dementia Patients (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/iadapt/carnahan.pdf
    January 01, 2014 - Few drugs have demonstrated efficacy in managing behavioral and psychological symptoms of dementia. … clinical decision aid and educational materials for providers and consumers to guide best use of these drugs

70. Final progress Report: Improving Over-the-Counter Medication Safety for Older Adults (pdf file)
    www.ahrq.gov/sites/default/files/2024-03/chui-report.pdf
    January 01, 2024 - more than 50% of these interactions involve an OTC medication.2 Four of the 10 most frequently used drugs … They are ibuprofen, aspirin, acetaminophen, and diphenhydramine.7 These four drugs also are available … ) than do anticoagulants (10.2%), one of the Department of Health and Human Services’ top priority drugs … FDA strengthens warning that non-aspirin nonsteroidal anti- inflammatory drugs (NSAIDs) can cause heart … (Lexi-Drugs(R)). 35. Lunceford JK.

71. Final Progress Report: UIC Center for Education and Research on Therapeutics Tools for Optimizing Prescribing, Monitoring and Education (TOP-MED) (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/lambert2-report.pdf
    January 01, 2024 - Scope Efforts to maximize the benefits and minimize the risks associated with drugs continue to be impeded … This can be done automatically for large sets of drugs and AEs. … Cost inputs included drugs, nursing labor, readmissions, and hospitalizations. … Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. … Estrogen implants: Embodiments of deeper problems in the marketing of drugs.

72. Final Progress Report: The elderly and OTC labeling information: A randomized controlled experiment test (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/sangasubana-report.pdf
    January 01, 2024 - Context: During the past three decades, risk perceptions of drugs have not been studied extensively; … even fewer studies have targeted OTC drugs specifically (Sangasubana, 2003; Strutton et al., 1992). … Drugs & Aging, 22:361-70. Jacoby J, Kaplan LB. (1972). … “Nonprescription drugs and the elderly.” American Family Practitioner, June:175-9. … “Prescription to over-the-counter switching of drugs.”

73. Proactive Postmarketing Surveillance: Overview and Lessons Learned from Medication Safety Research in the Veterans Health Administration (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol1/Advances-Campbell-R_106.pdf
    April 14, 2008 - Powerful medicines: The benefits, risks, and costs of prescription drugs. New York: Alfred A. … Report to the nation: Improving public health through human drugs. Rockville, MD: U.S. … drugs enhanced. … Drugs Aging 2005; 22: 877- 885. 33. French DD, Chirikos TN, Spehar A, et al. … Drugs and falls in community-dwelling older people: A national veterans study.

74. Clinical Questions about COVID-19: Questions & Answers for Healthcare Providers | Agency for Healthcare Research and Quality
    www.ahrq.gov/nursing-home/resources/clinical-questions-COVID-19.html
    January 01, 2021 - Drugs and Investigational Therapies. Patients with Asthma. Patients with Liver Disease.

75. Upper Respiratory Tract Infection: The Common Cold (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/respiratory-one-pager.pdf
    September 01, 2022 - and children ≥ 6 years of age:2-5 ‒ Analgesics (acetaminophen and nonsteroidal anti-inflammatory drugs … https://www.fda.gov/drugs/special- features/use-caution-when-giving-cough- and-cold-products-kids.

76. Technology for Improving Medication Monitoring in Nursing Homes (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol4/Lapane.pdf
    March 09, 2005 - • Compliance (whether the drugs are correctly administered). … The process that was developed for updating the drugs includes a reproducible process that uses FDA’ … The FDA pipeline includes drugs that are making their way through the FDA investigational and approval … Drugs Aging 1991;5:385–404. 6. Beers MH, Ouslander JG, Fingold SF, et al. … Drugs Aging 1995;7:203–11. 17. Gurwitz JH, Field TS, Avorn J, et al.

77. Final Progress Report: Clinical Prediction of Hepatotoxicity & Comparative Hepatic Safety of Medications (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/lo-report.pdf
    January 01, 2024 - Safety of newly approved drugs: implications for prescribing. JAMA 2002;287:2273-5. 4. … Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver. 2nd ed. … Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease. … Acute liver failure due to drugs. Semin Liver Dis 2008;28:175-87. 55. Bjornsson E, Olsson R. … Accessed at: http://www.fda.gov/downloads/Drugs/DrugSafety/UCM362444.pdf.

78. Final Progress Report: Encoding and Processing Patient Allergy Information in EHRs (pdf file)
    www.ahrq.gov/sites/default/files/2024-07/zhou-report.pdf
    January 01, 2024 - Epidemiological Studies Using MTERMS, we were able to describe the epidemiology of drugs allergies, … Drug-Induced Anaphylaxis Although drugs represent a common cause of anaphylaxis, few large studies of … Hypersensitivity Reactions Hypersensitivity reactions (HSRs) are immunologic responses to drugs. … Causative drugs and drug groups were assessed. … Contrast Allergen Documentation in the EHR We systematically identified medical imaging drugs and class

79. Appendix I. Initial Risk Factors | Agency for Healthcare Research and Quality
    www.ahrq.gov/research/findings/final-reports/ssi/ssiapi.html
    April 01, 2018 - Hospitalizations in Prior 12 Months   N Y     Surgical Site   N Y     Anesthetic Drugs … Colonization   Y Y     Preoperative Shower   Y Y     Immunosuppressive Drugs

80. Final Progress Report: Do Safety Warnings Change Prescribing Among the US Dialysis Population? (pdf file)
    www.ahrq.gov/sites/default/files/2024-01/thamer-report.pdf
    January 01, 2024 - (FDA) outlining new safety information about erythropoiesis- stimulating agents (ESAs), widely used drugs … Conversely, use of other intravenous drugs continued to increase in 2008: 12% for IV vitamin D, 4.8% … [http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088591.pdf] 29. … http://www.usrds.org/adr.htm http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088591.pdf Principal … Office of Inspector General: Medicare Reimbursement for Existing End-stage Renal Disease Drugs.